CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED) - USD ($) $ in Thousands	9 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
Cash Flows from Operating Activities:
Net income	$ 13,581	$ 11,478
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	3,543	3,100
Amortization on right-of-use assets	2,953	1,543
Provision for bad debts	2,150	5,103
Deferred income tax – net	3,484	1,712
Compensatory element of stock issuances		83
Stock issued for costs and expenses		1,941
Abandoned patents		1
Gain on forgiveness of PPP loan	(701)
(Increase) decrease in operating assets, net:
Accounts, medical and management fee receivable(s)	(4,950)	(9,551)
Notes receivable	32	36
Contract assets	(15)	(65)
Inventories	(705)	(323)
Income tax receivable		671
Prepaid expenses and other current assets	112	424
Other assets	132	(1)
Increase (decrease) in operating liabilities, net:
Accounts payable	(855)	(189)
Other current liabilities	(5,480)	(1,827)
Operating lease liabilities	(2,579)	(1,168)
Financing lease liabilities	(151)	(25)
Customer deposits	(370)	183
Contract liabilities	(15)
Other liabilities	(49)	14
Net cash provided by operating activities	10,117	13,140
Cash Flows from Investing Activities:
Purchases of property and equipment	(3,807)	(2,942)
Purchase of noncontrolling interests	(546)
Purchases of imaging facility		(1,123)
Cost of patents	(60)	(108)
Net cash used in investing activities	(4,413)	(4,173)
Cash Flows from Financing Activities:
Repayment of borrowings and capital lease obligations	(23)	(73)
Proceeds from debt		63
Distributions to noncontrolling interests	(4,131)	(4,950)
Net cash used in financing activities	(4,154)	(4,960)
Net Increase in Cash and Cash Equivalents	1,550	4,007
Cash and Cash Equivalents - Beginning of Period	44,460	36,802
Cash and Cash Equivalents - End of Period	$ 46,010	$ 40,809